Long Protocol and Growth Hormone in Poor Responders

The long down regulation protocol is widely used in the in vitro fertilization cycles, now it will be assessed regarding its efficacy, in poor responder females undergoing in vitro fertilization cycles, alone and after the addition of growth hormone.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Infertility Genital Diseases Urogenital Diseases

Age range

20 year–44 year

Sex eligibility

Female

Study type

Interventional

Phase

Phase 2

Primary location

Kasr el aini hospital

Cairo, 12211, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Poor responder females are those who posses two out of these three criteria:
Female age ≥40 years
Females who have at least one previous cancelled IVF cycle
POR according to AFC ≤ 5 or low AMH value.

Exclusion criteria

Females over 45 years
Females with FSH more than 20 IU/l
Females with previous ovarian surgery
Females suffering from causes of infertility other than poor ovarian response
Females refusing to be enrolled in the study

Treatment and study plan

growth hormone

Drug

Other names: Norditropin, Novo nordisk

Primary outcomes

Live birth rate

Time frame: 12 months

Fresh, Frozen, Cumulative

Sponsors and collaborators

Lead sponsor

Woman's Health University Hospital, Egypt

Other

Collaborators

Cairo University

Registry information

Official study title

Growth Hormone Adjuvant Therapy With Long Down Regulation Protocol in Poor Responders Undergoing In Vitro Fertilization Cycles: a Randomized Control Trial

Important dates

Study start: 2015
Primary completion: 2017
Study completion: 2017
First posted: Jan 14, 2015
Registry last updated: Nov 29, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed